Skip to main content
. Author manuscript; available in PMC: 2019 Sep 11.
Published in final edited form as: Curr Cancer Drug Targets. 2019;19(7):515–524. doi: 10.2174/1568009618666181018162117

Table 2.

Small molecular compounds that inhibit HSF1 activity.

Selective Compounds Effect on HSF1 Mechanism of Action References
KNK437 ↓HSP expression Unknown [97]
KNK423 ↓HSP expression Unknown [101]
“Compound 1” ↓HSF1 phosph. and HSP expression Unknown [103]
KRIBB11 ↓HSF1-induced transcription Binds to transactivation domain, prevents pTEFb recruitment [54, 104106]
Ly101-4b ↓HSF1 protein levels and HSP expression Unknown [108, 125]
Rohinitib (RHT) ↓HSE binding and HSP expression Binds to DNA binding domain to prevent HSE binding [83, 110]
PW3405 ↓HSF1 phosph. Unknown [111]
CCT251236 ↓HSP expression Unknown [112]
IHSF115 ↓HSF1 binding to HSE and HSP expression Binds DNA binding domain to prevent HSE binding [113]
HSF1 RNA Aptamer ↓HSE binding and HSP expression Binds DNA binding domain to prevent HSE binding [114117]
Natural Compounds
Quercetin ↓HSF1 phosph. and HSE binding Unknown [83, 118, 126]
Triptolide ↓HSP expression and transactivation Inhibits HSF1-induced transcription activation [83, 119, 120]
Rocaglamide A ↓HSE binding and HSP expression Binds to DNA binding domain to prevent HSE binding [83]